$HUM

Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

Humana (HUM) shares rose 12.3% to $434.84 after reporting improved Medicare Advantage Star Ratings and reaffirming FY26 EPS guidance. Other stocks gaining include Evolution Metals (EMAT) up 13.8%, Fastly (FSLY) up 10.2%, and Moderna (MRNA) up 7.7%.

Original reporting
Published Oct 9, 2026, 2:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 3:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$HUM
Bullish
high confidence
Mentioned
$HUM · $EMAT · $FSLY
Relevance
4/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$HUMBullishLow
01

Why it matters

The highlighted moves reflect short-term sentiment shifts; the underlying fundamentals vary by company, with Humana's Medicare rating being the most material.

02

Market read

The article signals a bullish tone for the highlighted stocks, but the overall market impact is modest as the moves are isolated.

03

What to watch

Potential regulatory scrutiny on Medicare star ratings and commodity price volatility could affect long-term performance.

Relevance 4/10Novelty 4/10Timing: Friday session

Background

The article is a market wrap highlighting several U.S. stocks that posted large intraday gains on Friday, each tied to a specific catalyst such as rating upgrades, revenue guidance, or analyst upgrades.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana reported improved 2027 Medicare Advantage Star Ratings and reaffirmed FY26 EPS guidance, driving a 12.3% jump.

Expected impact

likely upward pressure as investors price in stronger Medicare performance.

Evidence & confidence

Star rating lift signals higher future cash flows; guidance reaffirmation removes downside risk.

$EMATBullishMedium confidence
Context

Evolution Metals raised its FY26 revenue range, sending the stock up 13.8%.

Expected impact

potential continued upside as revenue expectations rise.

Evidence & confidence

Higher revenue guidance suggests better demand for its metal products.

$FSLYBullishMedium confidence
Context

Fastly received an Oppenheimer upgrade to Outperform with a $35 price target, lifting the stock 10.2%.

Expected impact

likely further upside as the upgrade attracts buyers.

Evidence & confidence

Upgrade reflects improved outlook for the cloud edge business.

Market effects

Healthcare Medicare segment gains confidence; metal commodities see demand optimism; cloud edge services receive analyst support.

U.S. equity market buoyed by multiple large-cap gains.

Limited to U.S. listed companies; no broader macro impact.

Counterpoint

Some investors may view the rapid price spikes as overbought and could consider profit-taking.

Key entities

  • Humana Inc

    Health insurer with improved Medicare Advantage star ratings.

  • Evolution Metals & Technologies Corp

    Metal producer that raised FY26 revenue guidance.

  • Fastly Inc

    Edge cloud provider upgraded by Oppenheimer.

Related articles

Med

Humana increased operating profit and improved adjusted margin

Humana reported Q3 revenue of SEK 2,592m, up 4% YoY, with adjusted operating profit increasing 6% to SEK 221m. EBITDA rose to SEK 360m, and net profit reached SEK 123m. Growth was driven by price increases and efficiency improvements in Sweden, while Norway showed strong organic growth. Humana was acquired by Ambea and will delist from Nasdaq Stockholm. The company did not provide a new earnings forecast.

$UNHMed

UnitedHealthcare and Humana cut Medicare Advantage plans for 1 mn

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans covering nearly 1 million members, withdrawing from less profitable markets. UnitedHealthcare is ending plans for 390,000 members, while Humana is cutting 600,000. Both companies are focusing on more profitable products and regions, according to reports. Rising medical costs are driving these changes, with insurers reducing flexible PPO plans and increasing out-of-pocket expenses for members.

$HUMMed

UnitedHealthcare and Humana Drop Medicare Advantage Plans for Almost 1 Million Seniors

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans affecting nearly 1 million Americans in 2027, citing higher medical expenses and profitability pressures. UnitedHealthcare will impact 390,000 members, focusing on PPO plans, while Humana will affect 600,000 members, targeting lower-performing plans. Both companies are also scaling back certain benefits for 2027, with UnitedHealthcare reducing dental benefits and Humana adjusting premium givebacks.

$HUMMed

Humana’s $2.8 bn BlackRock deal follows Medicare Advantage ratings recovery

Humana (HUM) agreed to a $2.8 bn deal with BlackRock, restructuring ownership of 150 CenterWell clinics. BlackRock acquires WCAS's majority stake, with Humana retaining minority ownership. The deal reduces Humana's balance sheet obligations. Humana's Medicare Advantage star ratings improved, potentially increasing 2028 bonus payments to $4.8 bn, per Evercore ISI. S&P affirmed Humana's BBB rating but maintained a negative outlook.